Daniel Char - 01 Feb 2024 Form 4 Insider Report for ImmunoGen, Inc.

Signature
/s/ Renee Lentini, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Feb 2024
Net transactions value
$0
Form type
4
Filing time
05 Feb 2024, 21:28:20 UTC
Previous filing
30 Nov 2022
Next filing
12 Feb 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGN Restricted Stock Unit Award $0 +22,825 $0.000000 22,825 01 Feb 2024 Common Stock 22,825 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
F2 The RSUs vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.